Webinar Available on Demand

Allogeneic Cell Therapy Webinar

Allogeneic cell therapies space are transforming the cell therapy landscape by offering a viable and scalable alternative to autologous treatments. This webinar delve into the differences between allogeneic and autologous therapies and highlighted the unique advantages and recent advancements driving the evolution of allogeneic solutions.

In our latest webinar, in collaboration with Hanson Wade Intelligence, we cut through the noise to take a 360-degree view of the allogeneic research and commercial landscape.

Allogeneic Cell Therapy Innovations

We discussed the potential of allogeneic therapies across oncology and non-oncology and featured insights on leading developers, therapeutic classes, and current targets. Additionally, our industry experts provided an overview of clinical market trends, regulatory landscapes, and strategic considerations to help stakeholders make informed decisions. Watch the recording now.

Our Experts

Rachel East Head Shot - Senior Research Analyst

Rachel East

 

House Speaker

Senior Research Analyst

Beacon

Ahmed Tajmohamed

 

House Speaker

Market Analyst

Hanson Wade Intelligence

Thomas Vickers

 

Moderator

Account Manager

Beacon

You May Also Be Interested In…

Learn More About Cell Therapy

What is Beacon Cell Therapy?
  • The Most Comprehensive Way to Search the Cell Therapy Development Landscape: Unique search ontologies based on Cell Therapy drug and trial characteristics
  • Market Leading Approach to Cell Therapy Preclinical & Clinical Data Curation: Manual curation of key Cell Therapy research and development data points by Cell Therapy research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cell Therapy company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Cell Therapy Request Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search